Christopher McMaster
Impact in
- Health Informatics top 5%
- Artificial Intelligence in Healthcare and Education
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 3
-
- Artificial Intelligence in Healthcare and Education 2
- Co-authors
- David F. L. Liew (14 shared papers)Philip C. Robinson (3 shared papers)Claire Owen (7 shared papers)Tue Wenzel Kragstrup (2 shared papers)Russell R. C. Buchanan (6 shared papers)Douglas E. V. Pires (2 shared papers)Wendy W. Chapman (2 shared papers)Bente Glintborg (1 shared paper)
- Journals
- Drug Safety (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)RMD Open (1 paper)Journal of Biomedical Informatics (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- AustraliaUnited StatesDenmark
In The Last Decade
Christopher McMaster
17 papers receiving 321 citations
Peers
Comparison fields: 5 of 54
- Health Informatics 53
- Toxicology 45
- Rheumatology 83
- Dermatology 21
- Pulmonary and Respiratory Medicine 66
Countries citing papers authored by Christopher McMaster
This map shows the geographic impact of Christopher McMaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McMaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McMaster more than expected).
Fields of papers citing papers by Christopher McMaster
This network shows the impact of papers produced by Christopher McMaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McMaster. The network helps show where Christopher McMaster may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher McMaster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 72 | |
| 2 | 2022 | 51 | |
| 3 | 2023 | 37 | |
| 4 | 2020 | 34 | |
| 5 | 2022 | 32 | |
| 6 | 2019 | 29 | |
| 7 | 2022 | 29 | |
| 8 | 2023 | 16 | |
| 9 | 2020 | 13 | |
| 10 | 2024 | 6 | |
| 11 | 2022 | 4 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 |
About Christopher McMaster
Christopher McMaster is a scholar working on Toxicology, Health Informatics, Rheumatology, Pulmonary and Respiratory Medicine and Health, having authored 17 papers that have together received 330 indexed citations. Recurring topics across this work include Vasculitis and related conditions (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Artificial Intelligence in Healthcare and Education (2 papers), Heart Failure Treatment and Management (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Orthopedic Infections and Treatments (1 paper) and Pharmaceutical Economics and Policy (1 paper). The work is most often cited by research in Health Informatics (53 citations), Toxicology (45 citations), Rheumatology (83 citations), Dermatology (21 citations) and Pulmonary and Respiratory Medicine (66 citations). Christopher McMaster has collaborated with scholars based in Australia, United States and Denmark. Frequent co-authors include David F. L. Liew, Philip C. Robinson, Claire Owen, Tue Wenzel Kragstrup, Russell R. C. Buchanan, Douglas E. V. Pires, Wendy W. Chapman, Bente Glintborg, Bent Winding Deleuran and Albert G. Frauman. Their work appears in journals such as Drug Safety, European Journal of Nuclear Medicine and Molecular Imaging, RMD Open, Journal of Biomedical Informatics and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.